Log in or Sign up for Free to view tailored content for your specialty!
Liver/Biliary Disorders News
COVID-19: Innovating health care to work toward hepatitis elimination
Despite the SARS-CoV-2 pandemic, WHO has not yet changed their elimination targets for viral hepatitis, nor should they.
COVID-19 impacts the global 2030 target to eliminate viral hepatitis
Prior to the COVID-19 pandemic, WHO set a target to eliminate viral hepatitis around the world by 2030. But, as focus necessarily turned toward the pandemic, the organization seems to now doubt viral hepatitis elimination goals will be met.
Log in or Sign up for Free to view tailored content for your specialty!
Alcohol use disorder links to higher mortality in IBD
Alcohol use disorder correlated with a higher risk for in-hospital mortality among patients with inflammatory bowel disease, according to a presentation at Digestive Disease Week.
Graft, patient survival improves in HIV, HCC liver transplant recipients
Outcomes have improved significantly among HIV/Hepatitis C virus-coinfected liver transplant recipients in the direct-acting antiviral era, according to data presented at the Digestive Disease Week.
Higher antimicrobial gene burden in patients with cirrhosis vs. IBD, other diseases
Patients with cirrhosis had a higher abundance of beta-lactamase, vancomycin and quinolone genes in their gut microbiota compared with patients with inflammatory bowel disease, chronic kidney disease and diabetes, according to a presentation from Digestive Diseases Week.
Diabetes drives increase in fatty liver, higher risk for fibrosis in the US
Prevalence of fatty liver in the United States increased significantly between 1999 and 2016 with high- and moderate-risk groups also growing, according to a presentation at Digestive Diseases Week.
Increased alcohol-related liver disease diagnoses amid SARS-CoV-2
Researchers reported a significant increase in alcohol-related liver disease diagnoses amid the SARS-CoV-2 pandemic, according to a presentation at Digestive Disease Week.
Liver disease, increased COVID-19 mental health worry
During the pandemic, 40% of people with liver disease worried about their mental health, according to the British Liver Trust.
Genfit announces the release of NASHnext
Genfit, in association with Labcorp, announced the launch of a noninvasive nonalcoholic steatohepatitis test for at-risk patients, according to a press release.
Volume on consults for alcohol-related GI, liver diseases remain elevated throughout COVID-19
Despite ongoing COVID-19 infection control restrictions, volumes of inpatient consults for alcohol-related gastrointestinal and liver diseases had significantly decreased at the onset of the COVID-19 pandemic, but quickly returned to normal levels, according to an expert presentation during a press conference in advance of Digestive Diseases Week.
-
Headline News
First US case of clade I mpox reported in California
November 18, 20242 min read -
Headline News
'On the frontlines of public health': Physicians leverage trust against firearm violence
November 19, 20246 min read -
Headline News
Data support early, continued lecanemab dosing for Alzheimer’s
November 19, 20242 min read
-
Headline News
First US case of clade I mpox reported in California
November 18, 20242 min read -
Headline News
'On the frontlines of public health': Physicians leverage trust against firearm violence
November 19, 20246 min read -
Headline News
Data support early, continued lecanemab dosing for Alzheimer’s
November 19, 20242 min read